ABL Bio Inc. (KOSDAQ:298380)
South Korea · Delayed Price · Currency is KRW 51,100
-2,800 (-5.19%)
Sep 22, 2026, 3:30 PM KST
ABL Bio Market Cap
ABL Bio has a market cap or net worth of 3.02 trillion as of September 21, 2026. Its market cap has decreased by -48.94% in one year.
Market Cap
3.02T
Enterprise Value
2.91T
Revenue
34.28B
Ranking
n/a
PE Ratio
n/a
Stock Price
51,100.00
ChartMarket Cap Chart
Since December 19, 2018, ABL Bio's market cap has increased from 608.61B to 3.02T, an increase of 395.84%. That is a compound annual growth rate of 22.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 3.02T | -72.63% |
| Dec 30, 2025 | 11.03T | 663.70% |
| Dec 30, 2024 | 1.44T | 22.53% |
| Dec 28, 2023 | 1.18T | 7.19% |
| Dec 29, 2022 | 1.10T | 5.54% |
| Dec 30, 2021 | 1.04T | -27.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Epis Holdings | 8.12T |
| SK Biopharmaceuticals | 6.08T |
| HLB Co., Ltd. | 3.94T |
| Peptron | 3.64T |
| LigaChem Biosciences | 3.03T |
| SK bioscience | 2.74T |
| OliX Pharmaceuticals | 2.54T |
| Voronoi | 2.38T |